Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
2019; Massachusetts Medical Society; Volume: 381; Issue: 26 Linguagem: Inglês
10.1056/nejmoa1912388
ISSN1533-4406
AutoresJean‐Claude Tardif, Simon Kouz, David D. Waters, Olivier F. Bertrand, Rafael Díaz, Aldo P. Maggioni, Fausto J. Pinto, Réda Ibrahim, Habib Gamra, Ghassan S. Kiwan, Colin Berry, José López‐Sendón, Petr Ošťádal, Wolfgang Köenig, Denis Angoulvant, Jean C. Grégoire, Marc-André Lavoie, Marie‐Pierre Dubé, David Rhainds, Mylène Provencher, Lucie Blondeau, Andreas Orfanos, Philippe L. L’Allier, Marie‐Claude Guertin, François Roubille,
Tópico(s)Pericarditis and Cardiac Tamponade
ResumoExperimental and clinical evidence supports the role of inflammation in atherosclerosis and its complications. Colchicine is an orally administered, potent antiinflammatory medication that is indicated for the treatment of gout and pericarditis.
Referência(s)